Automate Your Wheel Strategy on CAH
With Tiblio's Option Bot, you can configure your own wheel strategy including CAH - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CAH
- Rev/Share 931.2887
- Book/Share -11.0209
- PB -13.026
- Debt/Equity -3.0662
- CurrentRatio 0.9351
- ROIC 0.115
- MktCap 36194006580.0
- FreeCF/Share 7.7406
- PFCF 19.5643
- PE 23.2064
- Debt/Assets 0.1605
- DivYield 0.0134
- ROE -0.5205
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CAH | Wells Fargo | Equal Weight | Overweight | -- | $179 | June 3, 2025 |
| Upgrade | CAH | Jefferies | Hold | Buy | $140 | $150 | Feb. 5, 2025 |
| Upgrade | CAH | TD Cowen | Hold | Buy | $130 | $144 | Jan. 8, 2025 |
| Upgrade | CAH | Evercore ISI | In-line | Outperform | -- | $140 | Jan. 7, 2025 |
| Upgrade | CAH | BofA Securities | Neutral | Buy | $132 | $145 | Jan. 6, 2025 |
| Upgrade | CAH | Wells Fargo | Underweight | Equal Weight | $101 | $127 | Dec. 13, 2024 |
| Resumed | CAH | Mizuho | -- | Outperform | -- | $139 | Dec. 4, 2024 |
News
5 Dividend Growth Stocks to Boost Your Portfolio
Published: August 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Five dividend growth stocks, AGCO, VRT, TEL, CAH and WWD, stand out for their steady payouts, strong fundamentals and long-term upside potential.
Read More
Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) possesses solid growth attributes, which could help it handily outperform the market.
Read More
All You Need to Know About Cardinal (CAH) Rating Upgrade to Buy
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Read More
Should Value Investors Buy Cardinal Health (CAH) Stock?
Published: August 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Cardinal Health Board of Directors Approves Quarterly Dividend
Published: August 15, 2025 by: PRNewsWire
Sentiment: Neutral
DUBLIN, Ohio , Aug. 15, 2025 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on October 15, 2025 to shareholders of record at the close of business on October 1, 2025.
Read More
Cardinal Health to Acquire Solaris Health for Urology Expansion
Published: August 15, 2025 by: Zacks Investment Research
Sentiment: Positive
CAH is set to buy Solaris Health for $2.4B, boosting urology presence with 750+ providers and expanding Specialty Alliance reach.
Read More
After Plunging 9.1% in 4 Weeks, Here's Why the Trend Might Reverse for Cardinal (CAH)
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Negative
The heavy selling pressure might have exhausted for Cardinal (CAH) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Read More
Brokers Suggest Investing in Cardinal (CAH): Read This Before Placing a Bet
Published: August 13, 2025 by: Zacks Investment Research
Sentiment: Negative
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Read More
Cardinal Health to Extend Reach by Acquiring Solaris Health
Published: August 12, 2025 by: PYMNTS
Sentiment: Positive
Cardinal Health's multi-specialty management services organization (MSO), The Specialty Alliance, plans to acquire urology MSO Solaris Health. Cardinal Health will enable the acquisition by providing about $1.9 billion in cash to The Specialty Alliance and will own about 75% of The Specialty Alliance after the acquisition of Solaris Health, Cardinal Health said in a Tuesday (Aug.
Read More
Top Stock Movers Now: Hanesbrands, On Holding, Cardinal Health, and More
Published: August 12, 2025 by: Investopedia
Sentiment: Positive
U.S. equities gained at midday after the latest report on consumer inflation came in lower than expected, boosting hopes of a Federal Reserve rate cut. The Nasdaq and S&P 500 traded at record highs, and the Dow Jones Industrial Average was up as well.
Read More
CAH Q4 Earnings Beat Estimates, '26 EPS View Up, Stock Falls
Published: August 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal Health's fourth-quarter fiscal 2025 results benefit from solid Medical and Other segments' revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.
Read More
Cardinal Health, Inc. (CAH) Q4 2025 Earnings Call Transcript
Published: August 12, 2025 by: Seeking Alpha
Sentiment: Neutral
Cardinal Health, Inc. (NYSE:CAH ) Q4 2025 Earnings Conference Call August 12, 2025 8:30 AM ET Company Participants Aaron E. Alt - Chief Financial Officer Jason M.
Read More
4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks
Published: August 11, 2025 by: Zacks Investment Research
Sentiment: Negative
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
Read More
Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings?
Published: August 08, 2025 by: Zacks Investment Research
Sentiment: Neutral
The continued solid uptake of Cardinal Health's products is expected to have driven fiscal fourth-quarter revenues despite an uncertain macroeconomic environment.
Read More
What Analyst Projections for Key Metrics Reveal About Cardinal (CAH) Q4 Earnings
Published: August 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Beyond analysts' top-and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Read More
Should Value Investors Buy Cardinal Health (CAH) Stock?
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Cardinal Health Foundation expands Equity Rx to increase access to prescription medications, bringing total investment to $5M
Published: July 30, 2025 by: PRNewsWire
Sentiment: Neutral
Grant funds will also launch the development of Ohio's first statewide prescription drug repository DUBLIN, Ohio , July 30, 2025 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today the expansion of Equity Rx, to help meet the needs of people across Ohio and beyond who cannot afford their prescription medications. Launched as a pilot in Ohio in 2023, Equity Rx was created through a partnership of the Cardinal Health Foundation, the Charitable Healthcare Network (CHN) (an Ohio charitable healthcare organization) and St. Vincent de Paul Charitable Pharmacy in Cincinnati, Ohio.
Read More
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: July 25, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Read More
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Published: July 23, 2025 by: Zacks Investment Research
Sentiment: Negative
Here is how Cardinal Health (CAH) and Biotricity Inc. (BTCY) have performed compared to their sector so far this year.
Read More
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
Published: July 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Cardinal Health (CAH) Laps the Stock Market: Here's Why
Published: July 03, 2025 by: Zacks Investment Research
Sentiment: Neutral
In the closing of the recent trading day, Cardinal Health (CAH) stood at $164.93, denoting a +1.82% move from the preceding trading day.
Read More
Cardinal Health (CAH) Stock Falls Amid Market Uptick: What Investors Need to Know
Published: July 02, 2025 by: Zacks Investment Research
Sentiment: Negative
In the most recent trading session, Cardinal Health (CAH) closed at $161.98, indicating a -1.47% shift from the previous trading day.
Read More
Cardinal Health (CAH) is a Great Momentum Stock: Should You Buy?
Published: July 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
5 Must-Watch Stocks Favored by Brokers as 2H25 Begins
Published: July 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Brokers are bullish on CBRL, BGSF, ARCB, CAH and AN as improving estimates and value metrics signal strength for 2H25.
Read More
Are Investors Undervaluing Cardinal Health (CAH) Right Now?
Published: June 27, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Wall Street Bulls Look Optimistic About Cardinal (CAH): Should You Buy?
Published: June 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Read More
Cardinal Health, Inc. (CAH) Hit a 52 Week High, Can the Run Continue?
Published: June 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Cardinal (CAH) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Read More
Cardinal Health (CAH) is a Top-Ranked Value Stock: Should You Buy?
Published: June 16, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
Cardinal Health (CAH) is a Top-Ranked Momentum Stock: Should You Buy?
Published: June 13, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
About Cardinal Health, Inc. (CAH)
- IPO Date 1983-08-04
- Website https://www.cardinalhealth.com
- Industry Medical - Distribution
- CEO Jason M. Hollar
- Employees 47922